Skip to main content

Early-Life Screen Time Tied to Atypical Sensory Processing Outcomes in Toddlers

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 10, 2024 -- Early-life digital media exposure is associated with atypical sensory processing outcomes in toddlers, according to a study published online Jan. 8 in JAMA Pediatrics.

Karen Frankel Heffler, M.D., from Drexel University in Philadelphia, and colleagues examined the association between early-life digital media exposure (12, 18, and 24 months of age) and sensory processing outcomes among toddlers. The analysis included data from 1,471 participants in the National Children's Study.

The researchers found that screen exposure at 12 months of age was associated with doubled odds of being in the high category of low registration (odds ratio [OR], 2.05), while the odds of being in the low category instead of the typical category decreased for sensation seeking (OR, 0.55), sensation avoiding (OR, 0.69), and low registration (OR, 0.64). Greater screen exposure at 18 months of age was associated with an increased risk for high sensation avoiding (OR, 1.23) and low registration (OR, 1.23), while greater screen exposure at 24 months was associated with an increased risk for high sensation seeking (OR, 1.20), sensory sensitivity (OR, 1.25), and sensation avoiding (OR, 1.21).

"Further research is needed to understand why early media exposure is associated with specific sensory-related behaviors, including those seen in autism spectrum disorder, and if minimizing screen media at a young age can improve subsequent sensory-related outcomes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.